Por favor, use este identificador para citar o enlazar este Item:http://hdl.handle.net/20.500.12105/17109
Título
Pharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in Muscle.
Autor(es)
Arrabal, Sergio | Lucena, Miguel Angel | Canduela, Miren Josune | Ramos-Uriarte, Almudena | Rivera, Patricia | Serrano, Antonia | Pavón, Francisco Javier | Decara, Juan | Vargas, Antonio | Baixeras, Elena | Martín-Rufián, Mercedes | Márquez, Javier | Fernández-Llébrez, Pedro | De Roos, Baukje | Grandes, Pedro | Rodríguez de Fonseca, Fernando | Suárez, Juan
Fecha de publicación
2015-12-15
Idioma
Inglés
Tipo de documento
research article
Resumen
Cannabinoid CB1 receptors peripherally modulate energy metabolism. Here, we investigated the role of CB1 receptors in the expression of glucose/pyruvate/tricarboxylic acid (TCA) metabolism in rat abdominal muscle. Dihydrolipoamide dehydrogenase (DLD), a flavoprotein component (E3) of α-ketoacid dehydrogenase complexes with diaphorase activity in mitochondria, was specifically analyzed. After assessing the effectiveness of the CB1 receptor antagonist AM251 (3 mg kg(-1), 14 days) on food intake and body weight, we could identified seven key enzymes from either glycolytic pathway or TCA cycle--regulated by both diet and CB1 receptor activity--through comprehensive proteomic approaches involving two-dimensional electrophoresis and MALDI-TOF/LC-ESI trap mass spectrometry. These enzymes were glucose 6-phosphate isomerase (GPI), triosephosphate isomerase (TPI), enolase (Eno3), lactate dehydrogenase (LDHa), glyoxalase-1 (Glo1) and the mitochondrial DLD, whose expressions were modified by AM251 in hypercaloric diet-induced obesity. Specifically, AM251 blocked high-carbohydrate diet (HCD)-induced expression of GPI, TPI, Eno3 and LDHa, suggesting a down-regulation of glucose/pyruvate/lactate pathways under glucose availability. AM251 reversed the HCD-inhibited expression of Glo1 and DLD in the muscle, and the DLD and CB1 receptor expression in the mitochondrial fraction. Interestingly, we identified the presence of CB1 receptors at the membrane of striate muscle mitochondria. DLD over-expression was confirmed in muscle of CB1-/- mice. AM251 increased the pyruvate dehydrogenase and glutathione reductase activity in C2C12 myotubes, and the diaphorase/oxidative activity in the mitochondria fraction. These results indicated an up-regulation of methylglyoxal and TCA cycle activity. Findings suggest that CB1 receptors in muscle modulate glucose/pyruvate/lactate pathways and mitochondrial oxidative activity by targeting DLD.
Palabras clave
Músculos abdominales | Peso corporal | Cannabinoides | Metabolismo energético | Glucosa | Ratas | Obesidad
MESH
3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | Abdominal Muscles | Animals | Body Weight | Cannabinoids | Diet | Dihydrolipoamide Dehydrogenase | Down-Regulation | Electrophoresis | Energy Metabolism | Flavoproteins | Glucose | Glutathione Reductase | L-Lactate Dehydrogenase | Lactates | Mice | Mitochondria | Mitochondria, Muscle | Muscle Fibers, Skeletal | Obesity | Phosphates | Phosphopyruvate Hydratase | Piperidines | Proteomics | Pyrazoles | Pyruvaldehyde | Receptor, Cannabinoid, CB1 | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Tricarboxylic Acids | Triose-Phosphate Isomerase | Up-Regulation
Versión en línea
DOI
Aparece en las colecciones
Acceso a texto completo